What do dental studies say about using remimazolam for intravenous sedation?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18243805
Cited by: 0

Abstract

Remimazolam appears effective and safe for intravenous sedation in dental settings, showing advantages over traditional agents like midazolam in terms of onset and recovery times with fewer complications. Further research is needed to confirm these findings.

Fields of Study & Subjects

Anesthesia and Sedative Agents Dental Anxiety and Anesthesia Techniques Veterinary Pharmacology and Anesthesia

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
14 January 2026